TABLE 1.

Antibiotic resistance profile of 36 Acinetobacter isolates.

Antibiotic	All isolates (n = 36)				A. baumannii isolates (n = 24)				Non-baumannii Acinetobacter isolates (n = 12)
	MIC (μg/ml)			%Ra	MIC (μg/ml)			%Ra	MIC (μg/ml)			%Ra
	Range	MIC50	MIC90		Range	MIC50	MIC90		Range	MIC50	MIC90
Piperacillin	8 to >64	32	>64	38.9	8 to >64	>64	>64	50	8 to >64	32	>64	16.7
Ampicillin-sulbactam	1/2 to >8/16	1/2	4/8	5.6	1/2 to >8/16	2/4	8/16	8.3	1/2 to 4/8	1/2	2/4	0
Piperacillin-tazobactam	≤4/16 to >4/64	≤4/16	>4/64	22.2	≤4/16 to >4/64	4/32	>4/64	29.2	≤4/16 to >4/64	≤4/16	4/32	8.3
Ceftazidime	2 to >16	4	>16	16.7	4 to >16	4	>16	20.8	2 to >16	4	16	8.3
Cefepime	1 to >16	4	>16	13.9	2 to >16	4	>16	16.7	1 to >16	2	16	8.3
Imipenem	≤0.25 to >8	≤0.25	1	5.6	≤0.25 to >8	≤0.25	4	8.3	≤0.25 to 1	≤0.25	≤0.25	0
Meropenem	≤0.25 to >8	0.5	2	5.6	≤0.25 to >8	0.5	4	8.3	≤0.25 to 2	≤0.25	1	0
Doripenem	≤0.25 to >8	≤0.25	1	5.6	≤0.25 to >8	0.5	4	8.3	≤0.25 to 1	≤0.25	1	0
Gentamycin	0.5 to >8	0.5	>8	33.3	0.5 to >8	>8	>8	50	0.5 to 2	0.5	2	0
Tobramycin	0.5 to >8	1	>8	36.1	0.5 to >8	8	>8	50	0.5 to >8	0.5	2	8.3
Amikacin	≤1 to >32	2	4	2.8	2 to 16	2	4	0	≤1 to >32	2	8	1.3
Minocycline	≤0.25 to >8	0.5	2	2.8	≤0.25 to >8	0.5	4	4.2	≤0.25 to 4	≤0.25	1	0
Colistin	≤2 to 8	≤2	4	22.2	≤2 to 4	≤2	4	12.5	≤2 to >8	≤2	8	41.7
Ciprofloxacin	0.12 to >2	0.5	>2	33.3	0.12 to >2	>2	>2	50	0.12 to 1	0.25	1	0
Levofloxacin	≤1 to >4	≤1	>4	16.7	≤1 to >4	4	>4	25	≤1	≤1	≤1	0
Trimethoprim-sulfamethoxazole	≤19/1 to >38/2	>38/2	>38/2	61.1	≤19/1 to >38/2	>38/2	>38/2	66.7	≤19/1 to >38/2	>38/2	>38/2	50

^aResistant.